business
AbbVie to acquire Apogee Therapeutics in $10.9B deal
AbbVie to acquire Apogee Therapeutics in $10.9B deal
Read full story on Yahoo Finance → More top storiesAlso covered by
STAT News
STAT+: AbbVie to buy Apogee Therapeutics in nearly $11B deal
Bloomberg Markets
AbbVie to Buy Apogee Therapeutics for $10.9 Billion
Financial Times
AbbVie buys Apogee for $10.9bn to acquire inflammatory disease drug
Bloomberg Markets
AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop